Search results
Author(s):
Moza A Alzaabi
,
Amin Abdelsalam
,
Majid Alhammadi
,
et al
Added:
1 year ago
Author(s):
Antonio Luca Maria Parlati
,
Cristina Madaudo
,
Vincenzo Nuzzi
,
et al
Added:
11 months ago
Author(s):
Giulia Tamburrini
,
Celia de Cobos García
,
Teresa López Fernández
Added:
4 months ago
Author(s):
Artemio García-Escobar
,
Rosa Lázaro-García
,
Javier Goicolea-Ruigómez
,
et al
Added:
1 year ago
Author(s):
Josip A Borovac
,
Dino Miric
Added:
2 weeks ago
Author(s):
Ahmad Masri
Added:
3 months ago
HFSA 25 - Aficamten found to significantly improve NYHA and KCCQ-CSS scores in new 96-week data from FOREST-HCM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss findings from the FOREST-HCM trial, examining the sustained safety and efficacy of aficamten in patients with symptomatic nonobstructive hypertrophic cardiomyopathy.This phase 2 open-label study followed 34…
View more
Therese Heinonen
Job title: Associate Director of Medical and Scientific Affairs
Author
Hans-Peter Brunner-La Rocca
Research Area(s) / Expertise:
Author
Expertise
Eileen O’Meara
Research Area(s) / Expertise:
Author
Expertise
Young-Hoon Jeong
Author
